生命科学资讯

Generate, an AI-driven Flagship startup, pitches an IPO

Express Scripts reaches ‘landmark’ settlement with FTC in insulin suit

Eikon Therapeutics nets a $381M IPO amid burst of biotech offerings

Trump signs funding bill with PBM reforms, hospital-at-home and telehealth extensions

Novo shares tumble by double digits on grim sales outlook

Lilly soars again as fast-selling weight loss drugs top Wall Street projections

Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan

Pfizer dips on new data for obesity drug acquired in $10B deal

FDA launches ‘PreCheck’ program; AstraZeneca, Acadia drugs set back

Novo combination obesity shot meets goal in diabetes trial

Sanofi drug, inherited from Genzyme, goes 1-for-2 in rare disease trials

GSK walks away from pioneering Wave RNA editing drug

Building a robust in-process testing plan for cell therapy manufacturing success

Amgen gives up on its once-prized eczema drug

AstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC

Politicization runs deeper than ever at FDA, risking long-term impacts

The biopharma industry outlook on 2026: Optimism and tension

Sanofi expects vaccine sales growth to dip amid ‘challenging environment’

AstraZeneca strengthens China ties with planned $15B investment

Tenpoint wins FDA nod for combination presbyopia eye drop